9 September 2022
H&T Group PLC ("H&T" or the "Group")
Appointment of Non-Executive Director
H&T Group is pleased to announce that Simon Richard Walker will join the Board as a Non-Executive Director with effect from 15th September 2022.
Simon is an experienced financial risk management professional having spent 42 years at KPMG - retiring in 2022 after 30 years as a partner. Simon is a highly experienced board member with a portfolio of NED/Trustee positions, over the last five years he has held appointments with Charter Court Financial Services Limited as Risk Committee Chair, as Non-Executive Director for OSB GROUP PLC, with Leeds Theatre Trust Ltd as Non-Executive Director and he is also a Director of IWP Holdings Limited.
Peter McNamara, Non-Executive Chairman, commented:
"On behalf of the Board and wider H&T team, I am very pleased to welcome Simon to the Board. His appointment will broaden and deepen the expertise in financial risk management available to the Board. We look forward to his guidance over the coming years as the Group continues to execute on its growth strategy."
Enquiries
H&T Group plc
Chris Gillespie, Chief Executive +44(0)20 8225 2700
Diane Giddy, Chief Financial Officer
Shore Capital Ltd (Nominated Advisor and Broker) +44(0)20 7408 4090
Stephane Auton/Iain Sexton (Corporate Advisory)
Guy Wiehahn/Chloe Booker-Triolo (Corporate Broking)
Alma PR (Public Relations) +44(0)20 3405 0205
Sam Modlin handt@almapr.co.uk
Andy Bryant
Lily Soares Smith
Regulatory disclosures
In accordance with Schedule 2(g) of the AIM Rules, Simon Richard Walker, aged 63, holds or has held in the past 5 years the following directorships and partnerships:
Current directorships/partnerships |
Leeds Theatre Trust Limited |
Leeds Theatre CIC |
Leeds Playhouse (Enterprises) Limited |
IWP Holdings Limited |
Independent Wealth Planners UK Limited |
Onesavings Bank Plc |
OSB GROUP PLC |
Charter Court Financial Services Limited |
Previous directorships/partnerships within the last 5 years |
KPMG LLP |
There is no further information required to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 (g) of the AIM Rules for Companies.